<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03154034</url>
  </required_header>
  <id_info>
    <org_study_id>UHRegensburg1</org_study_id>
    <nct_id>NCT03154034</nct_id>
  </id_info>
  <brief_title>Cardiopulmonary Exercise Testing in Severe Mitral Regurgitation</brief_title>
  <official_title>Cardiopulmonary Exercise Testing in Severe Mitral Regurgitation - a Single Center, Observational Echocardiographic Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Regensburg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Regensburg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is the evaluation of cardiac and pulmonary response to
      cardiopulmonary exercise in severe mitral regurgitation and its variation under treatment
      (surgical mitral valve repair, percutaneous mitral valve repair, optimal medical treatment).
      The study is conducted as a prospective, observational, single-center study. Patients
      suffering from symptomatic severe mitral regurgitation will be eligible, if they are referred
      to the University Hospital of Regensburg, Germany, for further diagnostic procedures and
      heart team discussion. Cardiopulmonary exercise testing is performed comprising standardized
      stress echocardiography as well as ergospirometry. Additional detailed assessment will be
      conducted including standardized questionary, clinical examination, transesophageal
      echocardiography and measurement of biomarkers.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 13, 2014</start_date>
  <completion_date type="Anticipated">August 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>exercise-induced systolic pulmonary arterial pressure</measure>
    <time_frame>Change from Baseline Exercise-Induced Systolic Pulmonary Arterial Pressure at 1 year</time_frame>
    <description>exercise-induced systolic pulmonary arterial pressure measured by stress- echocardiography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>peak oxygen uptake (peakVO2)</measure>
    <time_frame>Change from Baseline peakVO2 at 1 year</time_frame>
    <description>peak oxygen uptake measured by ergospirometry</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Mitral Valve Regurgitation</condition>
  <condition>Pulmonary Hypertension</condition>
  <arm_group>
    <arm_group_label>Severe mitral regurgitation</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood (serum and plasma samples)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Symptomatic, severe mitral regurgitation. Aetiology and treatment of mitral regurgitation
        do not affect enrollment.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  symptomatic, severe mitral regurgitation

          -  referral for diagnostic work-up and heart team discussion

          -  declaration of informed consent

        Exclusion Criteria:

          -  contra-indication for cardiopulmonary stress examination (unstable angina pectoris,
             left main disease, abnormal electrolyte concentrations, acute decompensation)

          -  pregnancy

          -  exercise test on treadmill not possible (amputation of lower extremity, severe
             arthritis of lower extremities)

          -  no acceptable acoustic window at rest
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexander Dietl, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Regensburg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Regensburg - Department of Internal Medicine II</name>
      <address>
        <city>Regensburg</city>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.uniklinikum-regensburg.de/e/departments/internal-medicine-2/index.php</url>
    <description>Study center</description>
  </link>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 10, 2017</study_first_submitted>
  <study_first_submitted_qc>May 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 15, 2017</study_first_posted>
  <last_update_submitted>May 12, 2017</last_update_submitted>
  <last_update_submitted_qc>May 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Regensburg</investigator_affiliation>
    <investigator_full_name>Dr. Alexander Dietl</investigator_full_name>
    <investigator_title>Resident</investigator_title>
  </responsible_party>
  <keyword>Stress echocardiography</keyword>
  <keyword>Cardiopulmonary exercise testing</keyword>
  <keyword>ergospirometry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Mitral Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

